Skip to main content
scPharmaceuticals Inc. logo

scPharmaceuticals Inc. — Investor Relations & Filings

Ticker · SCPH ISIN · US8106481059 LEI · 549300F55SN4ZR2OA180 US Manufacturing
Filings indexed 413 across all filing types
Latest filing 2026-02-11 Major Shareholding Noti…
Country US United States of America
Listing US SCPH

About scPharmaceuticals Inc.

https://www.scpharmaceuticals.com/

scPharmaceuticals Inc. is a pharmaceutical company that develops and commercializes innovative solutions for outpatient care. The company specializes in drug-device combinations and therapies for cardiorenal conditions, including heart failure and chronic kidney disease. Its primary marketed product is FUROSCIX®, an FDA-approved on-body infuser for the subcutaneous administration of furosemide. This therapy is designed to treat fluid overload (edema) in adults with chronic heart failure, providing a convenient at-home alternative to intravenous treatments typically administered in a clinical setting.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-11 English
Regulatory Filings 2025
Regulatory Filings
2025-11-20 English
Regulatory Filings 2025
Regulatory Filings
2025-11-20 English
Regulatory Filings 2025
Regulatory Filings
2025-11-20 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.